Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
US To Sell $110 Bln In Reopened 8-Week Bills Thu

US To Sell $110 Bln In Reopened 8-Week Bills Thu

Dow JonesDow Jones2026/11/03 16:00

WASHINGTON (Dow Jones)--The U.S. Treasury plans to auction $110 billion in reopened 8-week bills Thursday.

The debt will settle on Nov. 10, 2026 and will mature Jan. 05, 2027.

The debt is a reopening of an issue first sold on Sept. 08, 2026.

The Federal Reserve holds $21.64 billion of maturing securities for its own account. Amounts bid by the Federal Reserve banks for their own account will be in addition to the public offering amount.

Noncompetitive tenders for the 8-week bills, available in minimum denominations of $100, must be received by 11:00 AM Eastern Time Thursday. Competitive tenders available in minimum denominations of $100, must be received by 11:30 AM Eastern Time.

The CUSIP number is 912797WN3.

(Data provided by the U.S. Treasury Dept.)

(MORE TO FOLLOW) Dow Jones Newswires

November 03, 2026 11:00 ET (16:00 GMT)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Dental treatment company vVardis has announced the terms for its $214 million US IPO.

智通财经•2026/11/09 06:41
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.

智通财经•2026/11/09 06:41
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

CoreWeave (CRWV.US) Faces Key Earnings Test: AI Cloud Debt Concerns Intensify as "Burning Cash for Growth" Model Faces Scrutiny

CoreWeave will release its third-quarter financial report. Whether it can demonstrate that its rapid revenue growth is sufficient to cover the rising financing costs and construction expenditures will directly determine the direction of market confidence.

智通财经•2026/11/09 06:37
CoreWeave (CRWV.US) Faces Key Earnings Test: AI Cloud Debt Concerns Intensify as "Burning Cash for Growth" Model Faces Scrutiny